This is a very sad fact: "40,000 women in the U.S. will die this year from breast cancer". PWRM should work harder to benifit the woman, and there are even more women to be saved in other countries. Go, BC-SeraPro™!
40,000 women in the U.S. will die this year from breast cancer Breast cancer is the Second leading cause of cancer deaths in women today $7 billion annually is spent on breast cancer diagnosis Women in the U.S., have a 1 in 8 chance of developing breast cancer Breast cancer is diagnosed at a rate of nearly 1 in every 3 cancers in women It is estimated that by the time breast cancer is detected it has been present for six to ten years
BC-SeraPro™ is a blood serum test designed to diagnose breast cancer in individuals. The test is based on proteomic technology in which a blood serum sample drawn from a patient will monitor the concentration of each protein biomarker residing in a panel of blood serum protein biomarkers to determine if a patient has breast cancer. The biomarkers in the panel have been selected for their ability to discriminate breast cancer patients from non-cancerous patients. Power3’s statistical model evaluates the quantitative information of the protein biomarkers and automatically assigns a probability score. The probability score indicates to the physician that the patient “has cancer” or is “cancer-free”. The score reflects how strongly the patient sample fits the biostatistical model and if the patient should be recommended for further follow-up by the clinician.
Blood serum collection is a routine procedure performed by a clinician. A small sample of blood is drawn from a vein. When a blood sample is collected and stored in a tube without anticoagulant, it forms a clot after 30-60 minutes. The liquid portion remaining is the blood serum. This serum sample is then frozen and transported to the Power3 Medical CLIA certified laboratory, utilizing pre-approved carriers/delivery service, where sample preparation and analysis begins.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.